Padmapriyadarsini Chandrasekaran
Natarajan Saravanan
Ramalingam Bethunaickan
Srikanth Tripathy4
- 1Department of Clinical Research, National Institute for Research in Tuberculosis, Chennai, India
- 2Department of Biochemistry and Clinical Pharmacology, National Institute for Research in Tuberculosis, Chennai, India
- 3Department of Immunology, National Institute for Research in Tuberculosis, Chennai, India
- 4National Institute for Research in Tuberculosis, Chennai, India
Nutrition plays a major role in the management of both acute and chronic diseases, in terms of body’s response to the pathogenic organism. An array of nutrients like macro- and micro-nutrients, vitamins, etc., are associated with boosting the host’s immune responses against intracellular pathogens including mycobacterium tuberculosis (M.tb). These nutrients have an immunomodulatory effects in controlling the infection and inflammation process and nutritional deficiency of any form, i.e., malnutrition may lead to nutritionally acquired immunodeficiency syndrome, which greatly increases an individual’s susceptibility to progression of infection to disease. This narrative review looks at the various mechanisms by which nutrition or its deficiency leads to impaired cell mediated and humoral immune responses, which in turn affects the ability of an individual to fight M.tb infection or disease. There is very little evidence in the literature that any specific food on its own or a specific quantity can alter the course of TB disease or be effective in the treatment of malnutrition. Further clinical trials or studies will be needed to recommend and to better understand the link between malnutrition, tuberculosis, and impaired immunity.
Introduction
Tuberculosis (TB) has existed for millennia and continues to remain a major global public health problem. It is an infectious disease caused by Mycobacterium tuberculosis (M.tb), typically affects the lungs but can also affect other sites and spreads when a person with TB expels the bacteria into the air while coughing or sneezing. TB is one of the top 10 causes of death worldwide and the leading cause of death from an infectious disease (1). World Health Organization estimates that, in 2016, there were 10.4 million new TB cases (including 1.2 million among HIV-infected individuals) worldwide. 90% of cases were in adults and 10% in children with a male:female ratio of 1.6:1. There were 1.4 million TB deaths in 2015, with an additional 0.4 million deaths resulting from TB disease among HIV-infected individuals (1). 5–15% of the estimated two to three billion people infected with M.tb will develop TB disease during their lifetime, the probability increasing among people with HIV (1).
Pathogenesis of TB
Pathogenesis of TB involves various steps beginning from the exposure to M.tb, the development of infection, the progression of infection to disease, and finally the outcome of the disease. A complex interaction between diverse groups of cells and cytokines are involved in the progression of one stage to the next in the journey of TB disease.
Exposure to M.tb
Exposure to M.tb occurs when an active TB patient releases the infectious droplets in the air during coughing, sneezing, or talking. The bacteria in the droplet nuclei are infective to another person when inhaled.
Primary Infection
The M.tb in the droplet nuclei when inhaled by another individual is carried to the alveoli where they infect macrophages and multiply inside them. Within 2–6 weeks, the infection is followed by cellular immune response generated by CD4+ T-lymphocytes and infected macrophages release cytokines and chemokines. In 70–90% of instances, the immune response of an individual is strong enough, and it will fight off the TB bacteria and not become infected.
Latent TB Infection (LTBI)
During M.tb infection, the host immune response is able to contain the mycobacterial infection at the site of infection in approximately 30% of cases, but is unable to “sterilize” them. These foci later become associated with a state of LTBI with M.tb where persons are healthy, asymptomatic, and the infection is present in an enclosed environment in a non-transmissible state. The cellular immune response leads to the formation of a granuloma and the infection is curtailed. It also generates a delayed-type hypersensitivity reaction. Globally in 2014, approximately 1.7 billion individuals were estimated to be latently infected with M.tb and form a reservoir for future TB disease (2).
Progression from LTBI to Active TB Disease
This can occur with weakening of immune responses. If person is unable to control the initial infection, it can progress to active primary disease as in children. If the infection is curtailed and goes into latency, with the weakening of the immune system, it can progress to disease even months or years later; by breakdown of granuloma and active uncontrolled replication of mycobacteria with resultant disease in lungs and other organs (3).
The likelihood of getting infected with M.tb as well as the subsequent development of active disease depends upon number of factors like the infectivity of the source case, proximity and duration of contact, susceptibility of the host and various social, behavioral, economic, and environmental factors like undernutrition, overcrowding, indoor air pollution, smoking, and alcohol addiction (4–7). Of these, undernutrition is the single most important predisposing factor for TB in many resource limited settings (8).
Nutrition and TB
An array of nutrients like macro- and micro-nutrients (vitamins, minerals, and trace elements) are associated with boosting the immune responses against intracellular pathogens like M.tb. These nutrients have an immunomodulatory effect in controlling the infection and inflammation process. Protein-energy or micronutrient deficiency leads to altered immune-homeostasis, which greatly increases an individual’s susceptibility to infections or progression of infection to disease. Human immunodeficiency virus is the most well-known cause of immunodeficiency worldwide leading on to acquired immunodeficiency syndrome, but the most prevalent cause of immunodeficiency is malnutrition otherwise known as nutritionally acquired immunodeficiency syndrome. Though studies have shown that both macro- and micro-nutrient deficiency increases the risk of TB by affecting host immunity (9), evidences to show the exact mechanism of how nutrition affects the host immune response is still not clear.
Immunity in TB
Mycobacterium tuberculosis infection induces both cell-mediated and humoral immune responses in an individual. It has been shown that B-cell deficiency leads to a higher bacterial burden and worse outcome following M.tb infection while antibodies to M.tb enhance internalization of mycobacteria by phagocytic cells (10, 11). These antibodies significantly increase the ability of macrophages to kill intracellular mycobacteria and lead to marked increase in M.tb specific cell-mediated immunity (11). Various types of inflammatory cytokines of both innate and adaptive immune systems coordinate the immune response of an individual to M. tb infection (12).
Malnutrition and Immunology
Malnutrition affects both the innate and adaptive immunity of an individual rendering them susceptible to a variety of infections. Phagocytosis and complement cascade are two main mechanisms involved with elimination of pathogenic organisms from the body. Complement system by itself can destroy microorganisms or the complement receptors present on the surface of phagocytes can mediate capture of pathogens. With malnutrition, both functions get compromised—the opsonic complement factor C3 as well as the phagocytic ability to ingest and kill pathogens are also reduced considerably (10, 11). In addition, the functioning of various antigen-presenting cell types like the B lymphocytes, macrophages, dendritic cells (DCs), and Kupffer cells are decreased in malnutrition (13). We have tried to give a brief narrative review of the role of different nutrients in altering the inflammatory processes and, thereby, host immunity to diseases like TB in the following section.
Protein Energy Malnutrition (PEM)
Malnutrition is known to have direct effects on T cells. Severe PEM provokes atrophy of thymus as well as peripheral lymphoid organs, which in turn reduces cell number (leukopenia), decreases CD4/CD8 ratio, increases numbers of CD4 and CD8 double-negative T cells, and increases the number of immature T cells in the peripheral blood (14). A major decrease in the expression of CD25 and CD27 (the molecules required for T cell activation and proliferation) was also demonstrated. Immune response of the gut mucosa is also affected by malnutrition. It results in flattened hypotrophic microvilli, reduced IgA secretion, and lymphocyte counts in Peyer’s patches (15). Malnourished children have shown reduced production of type 1 cytokines (IL-2 and IFN-γ), which are the main mediators of immunity (16). Such changes in cell-mediated immunity lead to increased susceptibility of an individual to infection. Similarly, low serum albumin levels (<2.7 g/dl) has been shown to be strongly and independently associated with in-hospital deaths due to TB (aOR 3.38, 95% CI 1.51–7.59; P = 0.001) (17).
Essential Fatty Acids
There are two classes of essential fatty acids [n6 and n3 polyunsaturated fatty acids (n6 and n3PUFA)], which share the common enzyme system for their metabolism and their metabolic end products are mostly distinct in action. There are contrasting evidences to support the effects of these fatty acids in M.tb survival and proliferation (18). One of the important mechanisms by which the M.tb survives in the macrophages is by inhibiting the membrane actin assembly, which is essential for the maturation of phagosomes. The in vitro studies on effect of lipids on M.tb survival in macrophages showed that adding eicosapentaenoic acid (n3 PUFA) to culture medium favor M.tb growth. The suggested mechanism for this is inhibition of actin filament assembly while arachidonic acid (n6 PUFA) promotes it (19). The same group tested the in vitro results in an animal model and found a contrasting observation that n3 PUFA promoted M.tb clearance while n6PUFA helped M.tb survival suggesting the presence of complex metabolic and immunologic interplay (20). The enrichment of anti-inflammatory n3PUFA in host cells is also beneficial for T-cell mediated immune reactions but detrimental to macrophage-mediated microbial clearance (21). The M.tb survival in the host depends on the regulation of “Eicosanoids”—the complex metabolic end products of n6PUFA. The virulent M.tb diverts the metabolic pathway toward the production of lipoxin A4 and thereby inhibits cyclooxygenase 2 and decreases the levels of prostaglandin E2 (PGE2), which is a metabolic end product of arachidonic acid. By limiting the PGE2, which is involved in cellular repair, M.tb produces a necrotic environment in macrophages and thereby proliferates further.
Sphingolipids
Sphingolipids are structural lipids, which include sphingomyelin, ceramide, and sphingosine 1-phosphate, which are abundant in neuronal tissue and considered important bioactive molecule of inflammation. Sphingosine-1-phosphate, with effects over calcium regulation, expression of growth factors and inflammatory cytokines are of major interest in the regulation of M.tb survival (22). There are several mechanisms proposed for the survival and proliferation of M.tb in the host cell by which the M.tb evades the defense mechanism of the host. One of them involves direct action over the bioactive lipids and thereby altering the calcium influx in to the cytosol. Upon binding of microbes with the surface membrane receptors of the macrophage, an enzyme called sphingosine kinase 1 (SPK1) gets activated. The activated SPK1 phosphorylates the sphingosine to sphingosine 1 P (S1P) and the bioactive S1P initiates a cascade of events to release the Ca2+ in the cytosol, which is essential for the maturation of the phagolysosome. The M.tb cell wall glycolipid lipoarabinomannan (LAM) dephosphorylates the SPK1 by stimulating the Src homology region 2 domain-containing phosphatase1 (SHP1) in host monocytes and prevents the translocation of SPK1 to the membrane and thereby prevents the maturation of the phagosome. The inhibitory activity of LAM over SPK1 is also very effective in decreasing the inflammatory molecules such as TNF-α, IL-12, etc., of the host (23). The immunomodulatory actions of M.tb such as intracellular release of LAM help M.tb to evade the adaptive immune clearance by suppression of the maturation of phagolysosome.
Vitamins
Many studies have reported vitamins as a key mediator of innate immune system by regulating the functions of both macrophages and DCs and immunomodulating the process of antibacterial functions, autophagosomes formation, autophagy, and cytokine production. Multiple vitamins have been shown to have a role in immunity against M.tb infection or disease (24–28).
Vitamin D has been recognized as a vital modulator of both innate and adaptive immune response against TB infection, enhancing the antimicrobial properties of the phagocytes viz., monocytes, macrophages, DCs, and neutrophils.
Modulator of Innate Immune Response
Essentially, 1, 25-dihydroxyvitamin D3 induces the differentiation of monocytes into macrophages at the site of infection and enhance the uptake of the bacterium by promoting phagocytosis (29, 30); upregulate specific markers like CD14, mannose receptor, DC sign over the surface of antigen-presenting cells to boost the phagocytic activity, and intracellular killing (30). Besides, Vitamin D also induces the expression of several antimicrobial peptides, particularly cathelicidin (CAMP) and β-defensin 2(DEFB4). Vitamin D also induces hCAP18, which triggers the autophagy mechanism of the infected cells, by mediating phagosome–lysosome fusion and plays a vital role in the elimination of the intracellular M.tb (31). In addition, vitamin D is found to downregulate the expression of HAMP (hepcidin antibacterial protein), which aids in the intracellular transport of iron, thereby suppressing the growth of the bacteria within macrophages (32).
Modulator of Adaptive Immune Response
Besides macrophages, DCs (especially the myeloid DCs) also get modulated during the antigen presentation process, by Vitamin D, during mycobacterial infection. Vitamin D suppresses DC differentiation and maturation by downregulating NF-Kb through transcription control of relb gene (33). Vitamin D also modulates T helper cells by downregulating the production of proinflammatory cytokines such as interferon-gamma (IFN-γ), interleukin (IL-6, IL-12), tumor necrosis factor (TNF-α), and other related chemokines and escalating the production of the anti-inflammatory cytokines like TGF-β, IL-4, and IL-10 (34, 35). Vitamin D also modulates the proinflammatory response by downregulating the TH1 and TH17 response and regulates the excessive inflammatory response during active mycobacterial infection. Nevertheless, vitamin D has suppressive role against proliferation of activated B cells, generation of plasma cells, and class switched memory cells, thereby reducing the levels of secreted immunoglobulin, which indirectly contributes to the downregulation of proinflammatory response and in turn promotes anti-inflammatory response by stimulating B-regs (36, 37). Vitamin D also modulates the inflammatory process by attenuating the expression of M.tb induced matrix metalloproteinase (MMPs) such as MMP-7, MMP-9, and MMP-10. With the help of CYP27B1 and Vitamin D receptors, Vitamin D3 induces cathelicidin gene encoded antimicrobial peptide LL37, which in turn increases the intracellular calcium levels and results in direct killing of M.tb. Increased levels of LL37 results in augmented differentiation of macrophages, bacterial killing through increased intracellular Ca2+ levels, and decreased M.tb-induced MMP 7, 9, and 10 and vitamin D-mediated TLR2 and 4 expression together with upregulation of IL-10. All these roles of Vitamin D have a definite impact on the progression and outcome of TB disease in an individual. Two meta-analyses have demonstrated that low serum vitamin D levels are associated with susceptibility to M.tb infection as well as progression to TB disease rather than low vitamin D levels being a consequence of the disease (38, 39). A study from South Africa has also identified that polymorphisms in gene associated with innate immunity, in combination with low vitamin D levels increase a child’s risk of developing TB disease or death (40).
Supplementation with vitamin D along with anti-TB treatment may be beneficial with respect to minimizing the excessive tissue damage that occurs during the active stage of TB disease. Several clinical trials have evaluated vitamin D supplementation as an adjunct therapy in the treatment for TB (41–44). However, results are conflicting, owing to variations in dose regimens and outcomes. Further investigations are needed to find the optimal concentration of vitamin D for supplementation with standard anti-TB drugs to optimize treatment, which could help to effectively manage both drug-sensitive and drug-resistant TB.
Metals
Essentially, metals like iron, manganese, copper, and zinc are very much needed for the survival of M.tb inside the macrophages. M.tb has accomplished features to acquire these metals from the cellular milieu and utilize them for survival and replication within the macrophages. Host immune system tackles the mycobacterial infection by sequestering metals like copper and zinc in the phagosomes beyond their normal levels and tries to kill them by metal poisoning. Alternatively, by means of nutritional immunity and with the help of translocation of metal transporter proteins, essential metals like iron and manganese will be depleted within the macrophages and thus prevent the replication of the bacilli (45, 46). In addition, iron homeostasis also differs between early and delayed TB-progressors, with higher ferritin and hepcidin concentrations observed among early TB-progressors among household contacts (47). It has been shown that both iron deficiency and overload exists in TB patients that affect the disease progression and clinical outcomes (48). Besides iron, manganese will also be depleted from the phagolysosomes through NRAMP1 with coordinated response of transferrin, ferritin, and hepcidin. Thus, the negative regulatory effect of iron and IFN-γ increases the antimicrobial function through increased production of IL-4/IL-10/IL-5/FOXP3, which results in decreased DCs maturation, function, and differentiation. In addition, pathways related to the production of Nos2 and TNFα mediate killing of M.tb. Innate immune response against M.tb can be strengthened by pumping of copper and zinc ions inside the phagolysosomes for bactericidal activity.
Minerals
In natural conditions, upon ingestion of immunogenic foreign bodies, the macrophages get stimulated and their intracellular Ca2+ ion concentration increases 10-fold than that of their non-stimulated state. The Ca2+ ions are very essential for several events associated with phagocytosis including activation of the Ca2+/CAM-dependent protein kinase II (CAMKII) and generation of reactive oxygen molecules. Selective inhibition of formation of Ca2+ CAM complex formation (pre translocation) or inhibition of CAMKII pathway on the surface of the phagosome (post-translocation) prevent the maturation of the phagosome (49). It is also been established that the effect of Ca2+/CAM/CAMKII complex on phagosome maturation is associated with series of events that are specifically involved in the phagosome–lysosome fusion (50). Table 1 gives an overview on the effect of macro and micro nutrient on immunomodulation that are discussed and referenced in this review.
Table 1. Role of macro- and micro-nutrients over immunomodulation during TB.
In brief, Figure 1 represents a schematic diagram of the role of all nutrients explained above during M.tb infection. Upon infection, a series of antimicrobial effector mechanisms will be triggered by macrophages. M.tb also inhibits cycoloxygenase2 (cox2) pathway and limits prostaglandin 2 (PGE2), which is shown to be involved in membrane repair and apoptosis. By limiting PGE2, M.tb diverts the apoptotic pathway toward necrosis, which is essential for M.tb survival and proliferation.
Figure 1. Tuberculosis: nutrients and immunomodulation.
Body Mass Index (BMI) and Regulatory Cytokines of TB
Body Mass Index is a reliable estimate of the nutritional status of an individual. An inverse log-linear relationship has been shown between BMI and the incidence of TB across different settings of TB burden—a 14% reduction in the incidence of TB per unit increase of BMI (51). The biological mechanism linking BMI with risk of TB remains an enigma. Cytokines of the innate and adaptive immune systems play an important role in mediating the immune response to M.tb. A recent study has shown a link between BMI and inflammatory cytokines of TB. Individuals with low BMI have diminished circulating levels of proinflammatory (IFN-γ, TNF-α, IL-22, IL-1α, IL-1β, and IL-6) cytokines but elevated levels of regulatory cytokines (IL-10, TGF-β, IL-5, IL-13) (52). This group demonstrated a positive correlation between the circulating levels of pro-inflammatory cytokines and high BMI (between 25 and 29.9) and a negative correlation between the circulating levels of anti-inflammatory cytokines and low BMI (53, 54). These data suggest a protective mechanism of BMI against progression of TB infection to disease by altering the cytokine milieu of an individual.
Boosting Immunity through Nutritional/Food Supplementation
The above evidences clearly establish the fact that chronic nutritional deficiency (under nutrition or malnutrition) compromises the innate and adaptive immunity of an individual, leading to immunodeficiency, which increases one’s susceptibility to disease contributing to increased morbidity and mortality (55). Number of clinical studies, trials, and meta-analysis of nutritional or food supplementation among TB patients have shown varied results in various settings. In general, it is known that supplementation of micro-/macro-nutrients to TB patients not only improves the body weight and BMI but also has an effect on T-cell function, sputum conversion, relapse, physical activity, and mortality (26, 28, 48, 56–60). Studies have also shown the effects of nutrient supplementation on the pharmacokinetics of the ATT drugs, which helps in improving the treatment outcome by increasing the bioavailability of the anti-TB drugs (61, 62). However, there is no documented evidence that any specific food on its own or a specific quantity can alter the course of TB disease or can for that matter be effective in the treatment of malnutrition.
Future Research
Though the relationship between nutritional status and immunology is very evident, many questions remain unanswered and needs further research to establish the clinical utility of this relationship. Few of the questions that can be answered through operational research in the field settings include
1. The ideal nutritional supplementation for the prevention and management of infectious diseases
2. Better understanding of interactions between immune signaling pathways and resistance to diseases
3. Advanced nutriogenomics studies for predisposition of the infectious diseases—in terms of transcriptomics, proteomics, and metabolomics with respect to dietary signals
4. To study the role of diet and lifestyle and how it affects the health
5. Role of nutrition among elderly and pediatric patient population to boost immunity
6. Effect of lipids over inflammation and infection, especially in TB and emergence of drug resistance
7. Association of impaired immune response and poor dietary intake
8. Association of TB infection and disease with Hidden hunger (micronutrient deficiency).
Conclusion
In general, poor nutrition leads to macro- and micro nutrient deficiencies, which can lead to immunodeficiency, both cell mediated and humoral immune response. This secondary immunodeficiency, in turn, affects one’s ability to fight infection resulting in increased susceptibility to diseases including TB. There seems to be a definite role for nutritional or food supplementation in alleviating the detrimental effects produced by malnutrition on immune response to TB. However, there is no documented evidence that any specific food on its own or a specific quantity can alter the course of TB disease or can for that matter be effective in the treatment of malnutrition. There is experimental evidence that some nutrients may be helpful but further clinical studies and randomized clinical trials will be needed for them to be recommended and to better understand the link between malnutrition, TB and impaired immunity.
Author Contributions
PC conceived the idea, collected data, wrote, and edited the manuscript. SN and RB contributed for writing the manuscript. ST edited the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgment
RB’s work has been supported by DBT Ramalingaswami fellowship, Ministry of Science and Technology, Government of India.
References
1. World Health Organization. Global Tuberculosis Report 2016. World Health Organization (2017). Available from: http://www.who.int/tb/publications/global_report/en/ (accessed October 6, 2017).
2. Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med (2016) 13(10):e1002152. doi:10.1371/journal.pmed.1002152
3. Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev (2003) 16(3):463–96. doi:10.1128/CMR.16.3.463-496.2003
4. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med (2009) 68(12):2240–6. doi:10.1016/j.socscimed.2009.03.041
5. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med (2007) 167(4):335–42. doi:10.1001/archinte.167.4.335
6. Lonnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis – a systematic review. BMC Public Health (2008) 8:289. doi:10.1186/1471-2458-8-289
7. Narasimhan P, Wood J, MacIntryre CR, Mathai D. Risk factors for tuberculosis. Pul Med (2013) 2013:11. doi:10.1155/2013/828939
8. Bhargava A, Chatterjee M, Jain Y, Chatterjee B, Kataria A, Bhargava M, et al. Nutritional status of adult patients with pulmonary tuberculosis in rural central India and its association with mortality. PLoS One (2013) 8(10):e77979. doi:10.1371/journal.pone.0077979
9. Legielski JP, McMurray DN. The relationship between malnutrition and TB: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis (2004) 8(3):286–98.
10. Maglione PJ, Xu J, Chan J. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterim tuberculosis. J Immunol (2007) 178(11):7222–34. doi:10.4049/jimmunol.178.11.7222
11. de Valliere S, Abate G, Blazevic A, Heuertz RM, Hoft DF. Enhancement of innate and cell mediated immunity by antimycobacterial antibodies. Infect Immun (2005) 73(10):6711–20. doi:10.1128/IAI.73.10.6711-6720.2005
12. Etna MP, Giacomini E, Severa M, Coccia EM. Pro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis. Semin Immunol (2014) 26:543–51. doi:10.1016/j.smim.2014.09.011
13. Abe M, Akbar F, Matsuura B, Horiike N, Onji M. Defective antigen-presenting capacity of murine dendritic cells during starvation. Nutrition (2003) 19:265–9. doi:10.1016/S0899-9007(02)00854-7
14. Savino W. The thymus gland is a target in malnutrition. Eur J Clin Nutr (2002) 56(Suppl 3):S46–9. doi:10.1038/sj.ejcn.1601485
15. Souza ME. Evaluation of the intestinal microbiota of individuals injured by biological materials in occupational accidents and subjected to antiretroviral prophylaxis. J Venom Anim Toxins Trop Dis (2007) 13(3):694. doi:10.1590/S1678-91992007000300012
16. Rodríguez L, González C, Flores L, Jiménez-Zamudio L, Graniel J, Ortiz R. Assessment by flow cytometry of cytokine production in malnourished children. Clin Diagn Lab Immunol (2005) 12(4):502–7. doi:10.1128/CDLI.12.4.502-507.2005
17. Matos ED, Moreira Lemos AC. Association between serum albumin levels and in-hospital deaths due to tuberculosis. Int J Tuberc Lung Dis (2006) 10(12):1360–6.
18. Anes E, Jordao L. Trick-or-treat: dietary lipids and host resistance to infectious disease. Mini Rev Med Chem (2008) 8(14):1452–8. doi:10.2174/138955708786786525
19. Anes E, Kühnel MP, Bos E, Moniz-Pereira J, Habermann A, Griffiths G. Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria. Nat Cell Biol (2003) 5(9):793–802. doi:10.1038/ncb1036
20. Jordao L, Lengeling A, Bordat Y, Boudou F, Gicquel B, Neyrolles O, et al. Effects of omega-3 and-6 fatty acids on Mycobacterium tuberculosis in macrophages and in mice. Microbes Infect (2008) 10(12):1379–86. doi:10.1016/j.micinf.2008.08.004
21. McMurray DN, Bonilla DL, Chapkin RS. n−3 Fatty acids uniquely affect anti-microbial resistance and immune cell plasma membrane organization. Chem Phys Lipids (2011) 164(7):626–35. doi:10.1016/j.chemphyslip.2011.07.003
22. Spiegel S, Milstien S. Sphingosine-1-phosphate, a key cell signaling molecule. J Biol Chem (2002) 277:25851. doi:10.1074/jbc.R200007200
23. Knutson KL, Hmama Z, Herrera-Velit P, Rochford R, Reiner NE. Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes. J Biol Chem (1998) 273:645–52. doi:10.1074/jbc.273.1.645
24. Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab (2007) 51:301–23. doi:10.1159/000107673
25. Tenforde MW, Yadav A, Dowdy DW, Gupte N, Shivakoti R, Yang WT, et al. Vitamin A and D deficiencies associated with incident tuberculosis in HIV-infected patients initiating antiretroviral therapy in multinational case-cohort study. J Acquir Immune Defic Syndr (2017) 75(3):e71–9. doi:10.1097/QAI.0000000000001308
26. Villamor E, Mugusi F, Urassa W, Bosch RJ, Saathoff E, Matsumoto K, et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. J Infect Dis (2008) 197:1499–505. doi:10.1086/587846
27. Madebo T, Lindtjørn B, Aukrust P, Berge RK. Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia. Am J Clin Nutr (2003) 78(1):117–22.
28. Seyedrezazadeh E, Ostadrahimi A, Mahboob S, Assadi Y, Ghaemmagami J, Pourmogaddam M. Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients. Respirology (2008) 13(2):294–8. doi:10.1111/j.1440-1843.2007.01200.x
29. Chandra G, Selvaraj P, Jawahar MS, Banurekha VV, Narayanan PR. Effect of vitamin D3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis. J Clin Immunol (2004) 24(3):249–57. doi:10.1023/B:JOCI.0000025446.44146.52
30. Estrella JL, Kan-Sutton C, Gong X, Rajagopalan M, Lewis DE, Hunter RL, et al. A novel in vitro human macrophage model to study the persistence of Mycobacterium tuberculosis using vitamin D (3) and retinoic acid activated THP-1 macrophages. Front Microbiol (2011) 2:67. doi:10.3389/fmicb.2011.00067
31. Shin DM, Yuk JM, Lee HM, Lee SH, Son JW, Harding CV, et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signaling. Cell Microbiol (2010) (11):1648–65. doi:10.1111/j.1462-5822.2010.01497.x
32. Bacchetta J, Zaritsky JJ, Sea JL, Chun RF, Lisse TS, Zavala K, et al. Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol (2013) 25(3):564–72. doi:10.1681/ASN.2013040355
33. Dong X, Lutz W, Shchroeder TM, Bachman LA, Westendorf JJ, Kumar R, et al. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. Proc Natl Acad Sci U S A (2005) 102(44):16008–12. doi:10.1073/pnas.0506516102
34. Selvaraj P, Harishankar M, Singh B, Banurekha VV, Jawahar MS. Effect of vitamin D3 on chemokine expression in pulmonary tuberculosis. Cytokine (2012) 60(1):212–9. doi:10.1016/j.cyto.2012.06.238
35. Coussens A, Timms PM, Boucher BJ, Venton TR, Ashcroft AT, Skolimowska KH, et al. 1α, 25-dihydroxyvitamin D3 inhibits matrix metalloproteinase induced by Mycobacterium tuberculosis infection. Immunology (2009) 127(4):539–48. doi:10.1111/j.1365-2567.2008.03024.x
36. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol (2007) 179:1634–47. doi:10.4049/jimmunol.179.3.1634
37. Selvaraj P, Harishankar M, Afsal K. Vitamin D: immuno-modulation and tuberculosis treatment. Can J Physiol Pharmacol (2015) 93(5):377–84. doi:10.1139/cjpp-2014-0386
38. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol (2008) 37(1):113–9. doi:10.1093/ije/dym247
39. Huang SJ, Wang XH, Liu ZD, Cao WL, Han Y, Ma AG, et al. Vitamin D deficiency and the risk of tuberculosis: a meta-analysis. Drug Des Devel Ther (2016) 11:91–102. doi:10.2147/DDDT.S79870
40. Gupta A, Montepiedra G, Gupte A, Zeldow B, Jubulis J, Detrick B, et al. Low vitamin-D levels combined with PKP3-SIGIRR-TMEM16J host variants is associated with tuberculosis and death in HIV-infected and -exposed infants. PLoS One (2016) 11(2):e0148649. doi:10.1371/journal.pone.0148649
41. Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley KA, Shenvi N, et al. High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial. Am J Clin Nutr (2015) 102(5):1059–69. doi:10.3945/ajcn.115.113886
42. Mily A, Rekha RS, Kamal SM, Arifuzzaman AS, Rahim Z, Khan L, et al. Significant effects of oral phenyl butyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One (2015) 10(9):e0138340. doi:10.1371/journal.pone.0138340
43. Daley P, Jagannathan V, John KR, Sarojini J, Latha A, Vieth R, et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis (2015) 15(5):528–34. doi:10.1016/S1473-3099(15)70053-8
44. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F, et al. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis. BMC Infect Dis (2013) 13:22. doi:10.1186/1471-2334-13-22
45. Neyrolles O, Wolschendorf F, Mitra A, Niederweis M. Mycobacteria, metals, and the macrophage. Immunol Rev (2015) 264(1):249–63. doi:10.1111/imr.12265
46. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell (2010) 142:24–38. doi:10.1016/j.cell.2010.06.028
47. Minchella PA, Donkor S, McDermid JM, Sutherland JS. Iron homeostasis and progression to pulmonary tuberculosis disease among household contacts. Tuberculosis (Edinb) (2015) 95(3):288–93. doi:10.1016/j.tube.2015.02.042
48. Isanaka S, Aboud S, Mugusi F, Bosch RJ, Willett WC, Spiegelman D, et al. Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania. PLoS One (2012) 7(5):e37350. doi:10.1371/journal.pone.0037350
49. Malik ZA, Iyer SS, Kusner DJ. Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages. J Immunol (2001) 166:3392–401. doi:10.4049/jimmunol.166.5.3392
50. Vergne I, Chua J, Deretic V. Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade. J Exp Med (2003) 198:653–9. doi:10.1084/jem.20030527
51. Lonnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol (2010) 39:149e55. doi:10.1093/ije/dyp308
52. Anuradha R, Munisankar S, Bhootra Y, Kumar NP, Dolla C, Kumaran P, et al. Coexistent malnutrition is associated with perturbations in systemic and antigen-specific cytokine responses in latent tuberculosis infection. Clin Vaccine Immunol (2016) 23:339–45. doi:10.1128/CVI.00009-16
53. Anuradha R, Munisankar S, Bhootra Y, Dolla C, Kumaran P, Babu S, et al. High body mass index is associated with heightened systemic and mycobacterial antigen specific pro-inflammatory cytokines in latent tuberculosis. Tuberculosis (2016) 101:E56–61. doi:10.1016/j.tube.2016.08.004
54. Kassa D, de Jager W, Gebremichael G, Alemayehu Y, Ran L, Fransen J, et al. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals. Tuberculosis (Edinb) (2016) 96:131–40. doi:10.1016/j.tube.2015.05.015
55. Kant S, Gupta H, Ahluwalia S. Significance of nutrition in pulmonary tuberculosis. Crit Rev Food Sci Nutr (2015) 55(7):955–63. doi:10.1080/10408398.2012.679500
56. Pakasi TA, Karyadi E, Suratih NM, Salean M, Darmawidjaja N, Bor H, et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutr J (2010) 9:41. doi:10.1186/1475-2891-9-41
57. Schön T, Idh J, Westman A, Elias D, Abate E, Diro E, et al. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis–a randomised trial. Tuberculosis (Edinb) (2011) 91(5):370–7. doi:10.1016/j.tube.2011.06.002
58. PrayGod G, Range N, Faurholt-Jepsen D. The effect of energy-protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled trial in Mwanza, Tanzania. Br J Nutr (2012) 107(2):263–71. doi:10.1017/S0007114511002832
59. Kawai K, Meydani SN, Urassa W, Wu D, Mugusi FM, Saathoff E, et al. Micronutrient supplementation and T cell-mediated immune responses in patients with tuberculosis in Tanzania. Epidemiol Infect (2014) 142(7):1505–9. doi:10.1017/S0950268813002495
60. Range N, Changalucha J, Krarup H, Magnussen P, Andersen AB, Friis H. The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two-by-two factorial trial in Mwanza, Tanzania. Br J Nutr (2006) 95(4):762–70. doi:10.1079/BJN20051684
61. Swaminathan S, Pasipanodya JG, Ramachandran G, Hemanth Kumar AK, Srivastava S, Deshpande D, et al. Drug concentration thresholds predictive of therapy failure and death in children with tuberculosis: bread crumb trails in random forests. Clin Infect Dis (2016) 63(Suppl 3):S63–74. doi:10.1093/cid/ciw471
Keywords: malnutrition and tuberculosis, nutrition and immunity of tuberculosis, vitamin D, sphingolipid, food supplementation for tuberculosis, Mycobacterium tuberculosis
Citation: Chandrasekaran P, Saravanan N, Bethunaickan R and Tripathy S (2017) Malnutrition: Modulator of Immune Responses in Tuberculosis. Front. Immunol. 8:1316. doi: 10.3389/fimmu.2017.01316
Received: 24 February 2017; Accepted: 29 September 2017;
Published: 18 October 2017
Edited by:
Hridayesh Prakash, University of Hyderabad, IndiaReviewed by:
Elsa Anes, Universidade de Lisboa, PortugalGaurav K. Gupta, National Institutes of Health (NIH), United States
Pietro Ghezzi, Brighton and Sussex Medical School, United Kingdom
Copyright: © 2017 Chandrasekaran, Saravanan, Bethunaickan and Tripathy. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Padmapriyadarsini Chandrasekaran, padmapriyadarsinic@nirt.res.in